S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NASDAQ:LFVN

LifeVantage (LFVN) Stock Forecast, Price & News

$6.45
-0.28 (-4.16%)
(As of 09/29/2023 ET)
Compare
Today's Range
$6.41
$6.74
50-Day Range
$4.72
$7.51
52-Week Range
$3.04
$7.89
Volume
26,575 shs
Average Volume
40,483 shs
Market Capitalization
$81.98 million
P/E Ratio
32.25
Dividend Yield
2.17%
Price Target
N/A

LifeVantage MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.08% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
1.13mentions of LifeVantage in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$175,227 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

226th out of 973 stocks

Pharmaceutical Preparations Industry

87th out of 450 stocks


LFVN stock logo

About LifeVantage (NASDAQ:LFVN) Stock

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LFVN Price History

LFVN Stock News Headlines

WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
LifeVantage Files Definitive Proxy Statement
The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
Q4 2023 LifeVantage Corp Earnings Call
LifeVantage (NASDAQ: LFVN)
3 Top Stocks to Buy in the #1 Ranked Industry
LifeVantage Extends Stock Repurchase Program
See More Headlines
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Company Calendar

Last Earnings
8/28/2023
Ex-Dividend for 9/22 Dividend
9/07/2023
Dividend Payable
9/22/2023
Today
9/29/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFVN
Employees
248
Year Founded
N/A

Profitability

Net Income
$2.54 million
Pretax Margin
1.87%

Debt

Sales & Book Value

Annual Sales
$213.40 million
Cash Flow
$0.52 per share
Book Value
$2.71 per share

Miscellaneous

Free Float
11,848,000
Market Cap
$83.38 million
Optionable
Optionable
Beta
0.85
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Steven R. Fife (Age 62)
    Pres, CEO & Director
    Comp: $588.99k
  • Mr. Carl A. Aure (Age 50)
    Chief Financial Officer
    Comp: $284.05k
  • Ms. Alissa Neufeld (Age 44)
    Gen. Counsel & Corp. Sec.
    Comp: $362.65k
  • Ms. Julie Boyster (Age 38)
    Chief Marketing Officer
    Comp: $244.62k
  • Mr. Eric E. Marchant
    VP of Compliance
  • Chris Taylor
    Director of Communications
  • Ms. Michelle Oborn-Virchow (Age 43)
    Sr. VP of HR
  • Ms. Calli Mott
    Sr. VP of Distributor Experience
  • Mr. Eiichi Shiokawa
    Managing Director - Japan













LFVN Stock - Frequently Asked Questions

How have LFVN shares performed in 2023?

LifeVantage's stock was trading at $3.72 on January 1st, 2023. Since then, LFVN stock has increased by 76.3% and is now trading at $6.56.
View the best growth stocks for 2023 here
.

Are investors shorting LifeVantage?

LifeVantage saw a decrease in short interest in September. As of September 15th, there was short interest totaling 110,600 shares, a decrease of 23.1% from the August 31st total of 143,800 shares. Based on an average daily trading volume, of 73,500 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.1% of the shares of the company are sold short.
View LifeVantage's Short Interest
.

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our LFVN earnings forecast
.

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) issued its earnings results on Monday, August, 28th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.20 by $0.03. The firm had revenue of $54.22 million for the quarter. LifeVantage had a trailing twelve-month return on equity of 9.27% and a net margin of 1.19%. During the same period in the previous year, the firm posted $0.01 earnings per share.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage announced a None dividend on Monday, August 28th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.435 per share on Friday, September 22nd. This represents a yield of 2.2%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for LFVN
.

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.14%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage issued an update on its FY 2024 earnings guidance on Monday, August, 28th. The company provided earnings per share (EPS) guidance of $0.52-$0.62 for the period. The company issued revenue guidance of $216.00 million-$226.00 million.

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $6.56.

How much money does LifeVantage make?

LifeVantage (NASDAQ:LFVN) has a market capitalization of $83.38 million and generates $213.40 million in revenue each year. The company earns $2.54 million in net income (profit) each year or $0.20 on an earnings per share basis.

How many employees does LifeVantage have?

The company employs 248 workers across the globe.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.

This page (NASDAQ:LFVN) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -